Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Human Gene Therapy
|
May 3, 2017
Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
Lalitha R Belur, Alexa Temme, Kelly M Podetz-Pedersen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 23, 2009
Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system
Elena L Aronovich, Jason B Bell, Shaukat A Khan, et al.
Frontiers in Molecular Neuroscience
|
May 27, 2021
Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
Lalitha R Belur, Megan Romero, Junggu Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 30, 2023
Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine
Cristina D Peterson, Jonathan J Waataja, Kelley F Kitto, et al.
Human Gene Therapy
|
October 13, 2022
Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of <i>Ex Vivo</i> Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells
Miles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I
Lalitha R Belur, Avery K Huber, Hillary Mantone, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Human Gene Therapy
|
May 3, 2017
Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
Lalitha R Belur, Alexa Temme, Kelly M Podetz-Pedersen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 23, 2009
Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system
Elena L Aronovich, Jason B Bell, Shaukat A Khan, et al.
Frontiers in Molecular Neuroscience
|
May 27, 2021
Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I
Lalitha R Belur, Megan Romero, Junggu Lee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 30, 2023
Long-term reversal of chronic pain behavior in rodents through elevation of spinal agmatine
Cristina D Peterson, Jonathan J Waataja, Kelley F Kitto, et al.
Human Gene Therapy
|
October 13, 2022
Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of <i>Ex Vivo</i> Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells
Miles C Smith, Lalitha R Belur, Andrea D Karlen, et al.
Molecular Therapy. Methods & Clinical Development
|
December 17, 2024
Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I
Lalitha R Belur, Avery K Huber, Hillary Mantone, et al.
Page
of 7